According to hormone receptor expression, 50.0% of carcinomas appeared to be hormone-dependent tumors (ERα-positive and PR-positive) and 30.8% were hormone-independent tumors (ERα-negative and PR-negative). Here, NR4A1 is linked to carcinoma.